Darden North, MD
Obstetrics & Gynecology · Flowood, MSNPI 1851434575
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,890 of the $5,084 with a category attached, or 76.5%. 34 manufacturers reported payments, led by Applied Medical Resources Corporation at 26.0% of the total. Reporting peaked in 2023 at $1,957 and has fallen 63.9% since, to $707 in 2025.
Across 229 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$1K
- AbbVie$1K
- Amgen$466
- Mayne Pharma Commercial LLC$390
- Astellas Pharma US Inc$333
- Hologic Sales And Service, LLC$176
- plus $1K from 28 others
What the payments were for
- Travel & lodging$1,19423%
- Food & beverage$3,89077%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 5 | $1,321 |
| AbbVie(2 entities) | 72 | $1,078 |
| Amgen | 19 | $466 |
| Mayne Pharma Commercial LLC | 29 | $390 |
| Astellas Pharma US Inc | 17 | $333 |
| Hologic Sales And Service, LLC | 10 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $152 |
| Intuitive Surgical | 1 | $113 |
| Organon | 15 | $110 |
| Lilly USA, LLC | 6 | $100 |
| Revvity, Inc. | 1 | $86 |
| Daiichi Sankyo Inc. | 4 | $74 |
| Coopersurgical, Inc. | 3 | $71 |
| Novo Nordisk | 5 | $70 |
| Fisher Scientific Company L.L.C. | 2 | $69 |
| Scynexis, Inc. | 4 | $60 |
| Shield Therapeutics Inc | 2 | $47 |
| Radius Health, Inc. | 3 | $39 |
| Pfizer | 3 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Convatec Inc. | 1 | $29 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Channel Medsystems, Inc. | 2 | $25 |
| Conmed Corporation | 1 | $22 |
| Innovation Technologies Inc | 1 | $20 |
| Merck | 1 | $20 |
| Lupin Inc. | 1 | $16 |
| Axonics, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Avanos Medical | 1 | $12 |
| Myovant Sciences Inc. | 1 | $12 |
| Aspira Women's Health Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$1,176
- EVENITY$238
- Da Vinci Surgical System$113
- Veozah$104
How this compares
$5,084 in reported general payments places this provider in the 85th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 53 | $29,876 |
| PremarinEstrogens, Conjugated | 40 | $13,461 |
| Estradiol | 212 | $5,056 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,039 |
| Ibandronate Sodium | 87 | $1,903 |
| DottiEstradiol | 14 | $1,691 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 18 | $1,257 |
| SynthroidLevothyroxine Sodium | 11 | $500 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 27 | $493 |
| Alendronate Sodium | 75 | $488 |
| Escitalopram Oxalate | 23 | $438 |
| Metronidazole | 13 | $416 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $393 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $334 |
| Atorvastatin Calcium | 29 | $274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $333 | $29,87653 claims |
| PfizerPremarin | $39 | $13,46140 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $152 | $5,03911 claims |
| AbbVieSynthroid | $1,078 | $50011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 318 obstetrics & gynecology providers in Mississippi.
Other obstetrics & gynecology in Flowood
- Ahmet BedestaniFlowood$41K
- Charles CarrollFlowood$12K
- Layson DenneyFlowood$7K
- Karen ColeFlowood$4K
- Temeka JohnsonFlowood$3K
- Michelle TaheriFlowood$3K
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Melissa BarnettTupelo$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.